These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12656958)

  • 1. Dual action antidepressants and some important considerations.
    Gupta RK; Tiller JW; Burrows GD
    Aust N Z J Psychiatry; 2003 Apr; 37(2):190-5. PubMed ID: 12656958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W; Kucia K
    Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
    Masand PS; Gupta S
    Ann Clin Psychiatry; 2002 Sep; 14(3):175-82. PubMed ID: 12585567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Review of antidepressants from the TCAs to the third generation drugs].
    Almási J; Rihmer Z
    Neuropsychopharmacol Hung; 2004 Dec; 6(4):185-94. PubMed ID: 15825674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of the new antidepressants.
    Nelson JC
    J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing a new generation of antidepressant drugs.
    Pinder RM
    Acta Psychiatr Scand Suppl; 1997; 391():7-13. PubMed ID: 9265946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants.
    Frazer A
    J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
    [No Abstract]   [Full Text] [Related]  

  • 9. [Depression and pain: novel clinical, neurobiological and psychopharmacological data].
    Jaracz J; Rybakowski J
    Psychiatr Pol; 2005; 39(5):937-50. PubMed ID: 16358593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two new antidepressants: mirtazapine and venlafaxine].
    Birkenhäger TK; Moleman P
    Ned Tijdschr Geneeskd; 1999 May; 143(18):934-7. PubMed ID: 10368708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A
    Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract]   [Full Text] [Related]  

  • 12. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.
    Gartlehner G; Hansen RA; Carey TS; Lohr KN; Gaynes BN; Randolph LC
    Int Clin Psychopharmacol; 2005 Mar; 20(2):59-69. PubMed ID: 15729080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
    Ishigooka J
    Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
    Stahl SM; Grady MM; Moret C; Briley M
    CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new antidepressants.
    Sambunaris A; Hesselink JK; Pinder R; Panagides J; Stahl SM
    J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine: clinical overview.
    Gorman JM
    J Clin Psychiatry; 1999; 60 Suppl 17():9-13; discussion 46-8. PubMed ID: 10446735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine: pharmacology in relation to adverse effects.
    Nutt D
    Acta Psychiatr Scand Suppl; 1997; 391():31-7. PubMed ID: 9265949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mirtazapine versus other antidepressive agents for depression].
    Knud Larsen J
    Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological justification for the use of new antidepressant drugs].
    Nowakowska E; Kus K; Bobkiewicz-Kozłowska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.